Anti-obesity treatment could cost as little as $3 per month: Study

A blockbuster anti-obesity and diabetes drug could cost as little as $3 per month to manufacture once it goes off patent later this month, researchers said Friday, providing a major opportunity to boost health in low- and middle-income countries.